GESTIÓN EN SALUD PÚBLICA: Funding News from Fogarty Int'l Center at NIH

miércoles, 3 de enero de 2018

Funding News from Fogarty Int'l Center at NIH

Funding news for global health researchers and partners from Fogarty at NIH

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Top NIH News

Budget update > The U.S. federal government, including Fogarty and all of NIH, is operating under a continuing resolution through January 19, 2018. Access information about appropriations for fiscal year 2018 from Congress.gov.

Funding Opportunities

Reminder: The NIH Office of Extramural Research (OER) is continuing to reissue many NIH funding opportunity announcements (FOAs) with information on the new FORMS-E grant application package for due dates on or after January 25, 2018, reflecting changes to the NIH definition of a clinical trial. Search the NIH Guide to Grants and Contracts for the most recent, accurate information on active NIH FOAs. "Section III. Eligibility Information" of each FOA specifies if foreign institutions are eligible to apply.

NIH funding opportunities focusing on global health and foreign collaboration.

Reissue of International Research Scientist Development Award (IRSDA)
Independent Clinical Trial Not Allowed (K01) (PAR-18-539)
Independent Clinical Trial Required (K01) (PAR-18-540)
Application Receipt/Submission Date(s): March 7, 2018; March 7, 2019; March 6, 2020

More about Fogarty's International Research Scientist Development Award (IRSDA)
Updated information about NIH clinical trial requirements for grants and contracts from NIH Office of Extramural Research

Improving Implementation of Seek, Test, Treat and Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01-Clinical Trial Required) (RFA-DA-18-017)
Application Receipt Date(s): April 13, 2018 and November 15, 2018
Limited Competition: Revision Applications for International Centers of Excellence for Malaria Research (U19 Clinical Trial Optional) (RFA-AI-17-044)
Application Receipt Date(s): May 30, 2018

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01- Clinical Trial Not Allowed) (RFA-DA-18-023)
Application Receipt Date(s): April 17, 2018
Human BioMolecular Atlas Program
Transformative Technology Development (UG3/UH3 Clinical Trials Not Allowed) (RFA-RM-17-025)
Tissue Mapping Centers (U54 Clinical Trials Not Allowed) (RFA-RM-17-027)
Application Receipt Date(s): March 2, 2018
Self-Management for Health in Chronic Conditions (R01 Clinical Trial Optional) (PA-18-376) and (R21 Clinical Trial Optional) (PA-18-384)
Application Receipt/Submission Date(s): Standard dates apply
Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional) (PA-18-377) and (R21 Clinical Trial Optional) (PA-18-381)
Application Receipt/Submission Date(s): Standard dates apply
Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional) (PA-18-507) and (R21 - Clinical Trial Optional) (PA-18-508)
Application Receipt/Submission Date(s): Standard dates apply
Early-life Factors and Cancer Development Later in Life (Clinical Trial Not Allowed) R01 (PA-18-529), R03 (PA-18-531) and R21 (PA-18-532)
Application Receipt/Submission Date(s): Standard dates apply
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) (PAR-18-513)
Application Receipt/Submission Date(s): March 29, 2018, then standard dates apply
Partnership for Aging and Cancer Research (U01 - Clinical Trial Not Allowed) (PAR-18-552)
Application Receipt/Submission Date(s): June 8, 2018

NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.

BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44 Clinical Trial Required) (RFA-NS-18-022)
Application Receipt Date(s): February 23, 2018, June 21, 2018, and more
Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed) (PAR-18-512) and (R41/R42 Clinical Trial Not Allowed) (PAR-18-514)
Application Receipt/Submission Date(s): Standard dates apply
Candidate Biomarker for Neurological Disease:
Clinical Validation (U44 - Clinical Trial Optional) (PAR-18-548)
Analytical Validation (U44 - Clinical Trial Optional) (PAR-18-549) and (U01 Clinical Trial Optional) (PAR-18-550)
Application Receipt/Submission Date(s): March 14, 2018; July 18, 2018; and more

Information related to opportunities from other organizations focusing on global health and foreign collaboration.

The Magill Fellowship, created by the ASTMH Council in partnership with the Bill & Melinda Gates Foundation, provides $50,000 for up to two years to one recipient to support mentorship, career and leadership development projects for ASTMH members in the early-to-middle stage of mid-career in LMICs focusing on leadership development in tropical medicine.
Submit concept papers to ASTMH by February 14, 2018.

Funding News

NIH funding news that may be relevant to global health researchers.

Revision: NIH Policy and Guidelines on the Inclusion of Individuals Across the Lifespan as Participants in Research Involving Human Subjects (NOT-OD-18-116)
Maintaining Integrity in NIH Peer Review: Responsibilities and Consequences (NOT-OD-18-115)
Notice Announcing the Removal of the Funding Pause for Gain-of-Function Research Projects (NOT-OD-17-071)
NIH Applicant Assistance Program (AAP) for New or Previously Unawarded Small Businesses (NOT-CA-18-031)